LCDX (Caliber Imaging & Diagnostics) Total Liabilities: $16.40 Mil (As of Mar. 2014)


What is Caliber Imaging & Diagnostics Total Liabilities?

Caliber Imaging & Diagnostics LCDX Total Liabilities is $16.40 Mil as of Mar. 2014.

Caliber Imaging & Diagnostics's Total Liabilities for the quarter that ended in Mar. 2014 was $16.40 Mil.

Caliber Imaging & Diagnostics's quarterly Total Liabilities declined from Sep. 2013 ($14.91 Mil) to Dec. 2013 ($14.90 Mil) but then increased from Dec. 2013 ($14.90 Mil) to Mar. 2014 ($16.40 Mil).

Caliber Imaging & Diagnostics's annual Total Liabilities increased from Dec. 2011 ($6.96 Mil) to Dec. 2012 ($10.30 Mil) and increased from Dec. 2012 ($10.30 Mil) to Dec. 2013 ($14.90 Mil).

Caliber Imaging & Diagnostics Total Liabilities Historical Data

* Premium members only.

The historical data trend for Caliber Imaging & Diagnostics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Caliber Imaging & Diagnostics Total Liabilities Chart

Caliber Imaging & Diagnostics Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13
Total Liabilities
9.78 10.44 6.96 10.30 14.90

Caliber Imaging & Diagnostics Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.42 14.77 14.91 14.90 16.40

Caliber Imaging & Diagnostics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Caliber Imaging & Diagnostics's Total Liabilities for the fiscal year that ended in Dec. 2013 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=7.411+(6.758+0.732
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=14.90

Total Liabilities=Total Assets (A: Dec. 2013 )-Total Equity (A: Dec. 2013 )
=2.408--12.493
=14.90

Caliber Imaging & Diagnostics's Total Liabilities for the quarter that ended in Mar. 2014 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=8.776+(0+7.619
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=16.40

Total Liabilities=Total Assets (Q: Mar. 2014 )-Total Equity (Q: Mar. 2014 )
=2.213--14.182
=16.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $16.40 Mil mean?
Caliber Imaging & Diagnostics (LCDX) has a Total Liabilities of $16.40 Mil as of Mar. 2014. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Caliber Imaging & Diagnostics and its competitors.
Is Caliber Imaging & Diagnostics' Total Liabilities too high?
Caliber Imaging & Diagnostics' current Total Liabilities is $16.40 Mil.
How does Caliber Imaging & Diagnostics' Total Liabilities compare to VICA and CRVW?
Caliber Imaging & Diagnostics' Total Liabilities of $16.40 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Devices & Instruments company?
A good Total Liabilities depends on the Medical Devices & Instruments industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Caliber Imaging & Diagnostics and its competitors. Caliber Imaging & Diagnostics's current Total Liabilities is $16.40 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Caliber Imaging & Diagnostics stock overvalued right now?
Caliber Imaging & Diagnostics (LCDX) has a current Total Liabilities of $16.40 Mil. The current Total Liabilities is $16.40 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Caliber Imaging & Diagnostics (LCDX), the current Total Liabilities is $16.40 Mil as of Mar. 2014. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Caliber Imaging & Diagnostics Business Description

Address 50 Methodist Hill Drive, Suite 1000, Rochester, NY, USA, 14623
Caliber Imaging & Diagnostics Inc is a medical device company engaged in developing, manufacturing, marketing & selling point-of-care cellular imaging systems to diagnose skin cancer. It offers clinical imaging and research imaging solutions that shows tissue at the cellular level. Its products portfolio includes; VivaScope; VivaScope 3000, 1500 & 2500; and VivaNet and VivaScan.